|
1
|
Banno K, Yanokura M, Iida M, Masuda K and
Aoki D: Carcinogenic mechanisms of endometrial cancer: Involvement
of genetics and epigenetics. J Obstet Gynaecol Res. 40:1957–1967.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yeramian A, Moreno-Bueno G, Dolcet X,
Catasus L, Abal M, Colas E, Reventos J, Palacios J, Prat J and
Matias-Guiu X: Endometrial carcinoma: Molecular alterations
involved in tumor development and progression. Oncogene.
32:403–413. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Eritja N, Chen BJ, Rodriguez-Barrueco R,
Santacana M, Gatius S, Vidal A, Martí MD, Ponce J, Bergadà L,
Yeramian A, et al: Autophagy orchestrates adaptive responses to
targeted therapy in endometrial cancer. Autophagy. 13:608–624.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Colombo N, Creutzberg C, Amant F, Bosse T,
González-Martín A, Ledermann J, Marth C, Nout R, Querleu D, Mirza
MR, et al: ESMO-ESGO-ESTRO consensus conference on endometrial
cancer: Diagnosis, treatment and follow-up. Ann Oncol. 27:16–41.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ramon LA, Braza-Boils A, Gilabert J,
Chirivella M, España F, Estellés A and Gilabert-Estellés J:
microRNAs related to angiogenesis are dysregulated in endometrioid
endometrial cancer. Hum Reprod. 27:3036–3045. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhao C, Sun W, Zhang P, Ling S, Li Y, Zhao
D, Peng J, Wang A, Li Q, Song J, et al: miR-214 promotes
osteoclastogenesis by targeting Pten/PI3k/Akt pathway. RNA Biol.
12:343–353. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Madhavan B, Yue SJ, Galli U, Rana S, Gross
W, Müller M, Giese NA, Kalthoff H, Becker T, Büchler MW and Zöller
M: Combined evaluation of a panel of protein and miRNA
serum-exosome biomarkers for pancreatic cancer diagnosis increases
sensitivity and specificity. Int J Cancer. 136:2616–2627. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li Z, Yu X, Shen J and Jiang Y: MicroRNA
dysregulation in uveal melanoma: A new player enters the game.
Oncotarget. 6:4562–4568. 2015.PubMed/NCBI
|
|
11
|
Zeng B, Shi W and Tan G: miR-199a/b-3p
inhibits gastric cancer cell proliferation via down-regulating
PAK4/MEK/ERK signaling pathway. BMC Cancer. 18:342018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li S, Luo C, Zhou J and Zhang Y:
MicroRNA-34a directly targets high-mobility group box 1 and
inhibits the cancer cell proliferation, migration and invasion in
cutaneous squamous cell carcinoma. Exp Ther Med. 14:5611–5618.
2017.PubMed/NCBI
|
|
13
|
Zhao X, Zhu D, Lu C, Yan D, Li L and Chen
Z: MicroRNA-126 inhibits the migration and invasion of endometrial
cancer cells by targeting insulin receptor substrate 1. Oncol Lett.
11:1207–1212. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Faversani A, Amatori S, Augello C, Colombo
F, Porretti L, Fanelli M, Ferrero S, Palleschi A, Pelicci PG,
Belloni E, et al: miR-494-3p is a novel tumor driver of lung
carcinogenesis. Oncotarget. 8:7231–7247. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li XT, Wang HZ, Wu ZW, Yang TQ, Zhao ZH,
Chen GL, Xie XS, Li B, Wei YX, Huang YL, et al: miR-494-3p
regulates cellular proliferation, invasion, migration and apoptosis
by PTEN/AKT signaling in human glioblastoma cells. Cell Mol
Neurobiol. 35:679–687. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shen PF, Chen XQ, Liao YC, Chen N, Zhou Q,
Wei Q, Li X, Wang J and Zeng H: MicroRNA-494-3p targets CXCR4 to
suppress the proliferation, invasion, and migration of prostate
cancer. Prostate. 74:756–767. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lu CJ, Shan ZX, Hong J and Yang L:
MicroRNA-92a promotes epithelial-mesenchymal transition through
activation of PTEN/PI3K/AKT signaling pathway in non-small cell
lung cancer metastasis. Int J Oncol. 51:235–244. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sun K, Wang S, He J, Xie Y, He Y, Wang Z
and Qin L: NCOA5 promotes proliferation, migration and invasion of
colorectal cancer cells via activation of PI3K/AKT pathway.
Oncotarget. 8:107932–107946. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang S, Wang M, Li Q and Zhu P: miR-101
reduces cell proliferation and invasion and enhances apoptosis in
endometrial cancer via regulating PI3K/Akt/mTOR. Cancer Biomark.
21:179–186. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li L, Qu YW and Li YP: Over-expression of
miR-1271 inhibits endometrial cancer cells proliferation and
induces cell apoptosis by targeting CDK1. Eur Rev Med Pharmacol
Sci. 21:2816–2822. 2017.PubMed/NCBI
|
|
22
|
Liu K, Liu S, Zhang W, Jia B, Tan L, Jin Z
and Liu Y: miR-494 promotes cell proliferation, migration and
invasion, and increased sorafenib resistance in hepatocellular
carcinoma by targeting PTEN. Oncol Rep. 34:1003–1010. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Weng JH, Yu CC, Lee YC, Lin CW, Chang WW
and Kuo YL: miR-494-3p induces cellular senescence and enhances
radiosensitivity in human oral squamous carcinoma cells. Int J Mol
Sci. 17:E10922016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Qiu HF, Li J, Clark LH, Jackson AL, Zhang
L, Guo H, Kilgore JE, Gehrig PA, Zhou C and Bae-Jump VL: JQ1
suppresses tumor growth via PTEN/PI3K/AKT pathway in endometrial
cancer. Oncotarget. 7:66809–66821. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang J, Yang Y, Zhang Z, He Y, Liu Z, Yu
Y, Wu S, Cai B and Feng Y: Gankyrin plays an essential role in
estrogen-driven and GPR30-mediated endometrial carcinoma cell
proliferation via the PTEN/PI3K/AKT signaling pathway. Cancer Lett.
339:279–287. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cancer Genome Atlas Research Network, ;
Kandoth C, Schultz N, Cherniack AD, Akbani R, Liu Y, Shen H,
Robertson AG, Pashtan I, Shen R, et al: Integrated genomic
characterization of endometrial carcinoma. Nature. 497:67–73. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mutter GL, Lin MC, Fitzgerald JT, Kum JB,
Baak JP, Lees JA, Weng LP and Eng C: Altered PTEN expression as a
diagnostic marker for the earliest endometrial precancers. J Natl
Cancer Inst. 92:924–931. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu C, Liu ZK, Li X, Tang XJ, He JJ and Lu
SY: MicroRNA-1297 contributes to tumor growth of human breast
cancer by targeting PTEN/PI3K/AKT signaling. Oncol Rep.
38:2435–2443. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Huang ZJ, Zhu JJ, Yang XY and Biskup E:
NEDD4 promotes cell growth and migration via PTEN/PI3K/AKT
signaling in hepatocellular carcinoma. Oncol Lett. 14:2649–2656.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu CJ, Wu HB, Li YY, Shen L, Yu R, Yin H,
Sun T, Sun C, Zhou Y and Du Z: SALL4 suppresses PTEN expression to
promote glioma cell proliferation via PI3K/AKT signaling pathway. J
Neurooncol. 135:263–272. 2017. View Article : Google Scholar : PubMed/NCBI
|
